| Identification | Back Directory | [Name]
L-Tyrosine, 3-hydroxy-, monosodium salt (9CI) | [CAS]
63302-01-2 | [Synonyms]
Levodopa sodium
L-Tyrosine, 3-hydroxy-, monosodium salt (9CI) | [Molecular Formula]
C9H12NNaO4 | [MOL File]
63302-01-2.mol | [Molecular Weight]
221.19 |
| Hazard Information | Back Directory | [Description]
Levodopa is the naturally occurring form of DIHYDROXYPHENYLALANINE and the immediate precursor of DOPAMINE. Unlike dopamine itself, it can be taken orally and crosses the blood-brain barrier. It is rapidly taken up by dopaminergic neurons and converted to DOPAMINE. | [in vitro]
SH-SY5Y cells were treated with CA (carnosic acid) for 18 h, and then co-treated with 400 μM L-dopa for the indicated time points. The results showed that pretreatment of CA attenuated the cell death and nuclear condensation induced by L-dopa. In conclusion, CA ameliorates the development of LID via regulating the D1R signaling and prevents L-dopa-induced apoptotic cell death through modulating the ERK1/2-c-Jun and inducing the parkin._x000D_
_x000D_
Reference: Front Pharmacol. 2021 Aug 9;12:703894. https://pubmed.ncbi.nlm.nih.gov/34434108/ | [in vivo]
These results confirm previous findings that rotenone-induced motor and non-motor problems were alleviated by the Active diet (AD). Levodopa showed an additive beneficial effect on rotarod performance in rotenone-treated mice fed with the AD._x000D_
_x000D_
Reference: Front Aging Neurosci. 2018 Aug 3;10:237. https://pubmed.ncbi.nlm.nih.gov/30127735/ | [target]
L-DOPA (Levodopa) sodium is an orally active metabolic precursor of neurotransmitters dopamine. |
|
|